HEMOXIN Trademark

Trademark Overview

On Wednesday, December 23, 2009, a trademark application was filed for HEMOXIN with the United States Patent and Trademark Office. The USPTO has given the HEMOXIN trademark a serial number of 77900260. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 12, 2013. The HEMOXIN trademark is filed in the Pharmaceutical Products category with the following description:

Nutraceutical preparations for treating and conducting medical research in the field of sickle cell disease
hemoxin

General Information

Serial Number77900260
Word MarkHEMOXIN
Filing DateWednesday, December 23, 2009
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 12, 2013
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 18, 2010

Trademark Statements

Goods and ServicesNutraceutical preparations for treating and conducting medical research in the field of sickle cell disease

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, December 31, 2009
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNOT AVAILABLE
Party Type20 - Owner at Publication
Legal Entity Type01 - Individual
AddressHighland Park, NJ 08904
Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressHighland Park, NJ 08904

Trademark Events

Event DateEvent Description
Monday, August 12, 2013ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, August 12, 2013ABANDONMENT - NO USE STATEMENT FILED
Friday, January 11, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 10, 2013EXTENSION 5 GRANTED
Monday, January 7, 2013EXTENSION 5 FILED
Monday, January 7, 2013TEAS EXTENSION RECEIVED
Tuesday, July 10, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, July 7, 2012EXTENSION 4 GRANTED
Saturday, July 7, 2012EXTENSION 4 FILED
Saturday, July 7, 2012TEAS EXTENSION RECEIVED
Saturday, January 14, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 13, 2012EXTENSION 3 GRANTED
Thursday, January 12, 2012EXTENSION 3 FILED
Thursday, January 12, 2012TEAS EXTENSION RECEIVED
Tuesday, July 19, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 18, 2011EXTENSION 2 GRANTED
Wednesday, July 13, 2011EXTENSION 2 FILED
Wednesday, July 13, 2011TEAS EXTENSION RECEIVED
Friday, April 1, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 31, 2011EXTENSION 1 GRANTED
Thursday, January 13, 2011EXTENSION 1 FILED
Tuesday, March 29, 2011CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, March 22, 2011TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 22, 2011EXTENSION RECEIVED WITH TEAS PETITION
Tuesday, March 22, 2011PETITION TO REVIVE-GRANTED
Tuesday, March 22, 2011TEAS PETITION TO REVIVE RECEIVED
Monday, February 14, 2011ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, February 14, 2011ABANDONMENT - NO USE STATEMENT FILED
Tuesday, July 13, 2010NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 18, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 18, 2010PUBLISHED FOR OPPOSITION
Friday, April 9, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, April 9, 2010ASSIGNED TO LIE
Tuesday, March 23, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 23, 2010ASSIGNED TO EXAMINER
Thursday, December 31, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, December 26, 2009NEW APPLICATION ENTERED IN TRAM

Related Keywords

hemoxin field sickle cell disease research medical preparations treating conducting nutraceutical